GO
Loading...

Patents

More

  • WASHINGTON, April 25- A U.S. appeals court on Friday revived patent claims Apple made against Google's Motorola Mobility unit that had been dismissed shortly before trial, giving the iPhone maker another chance to seek a sales ban against its smartphone competitor.

  • Xilinx Inc eventually asked a California federal judge to declare those IV patents invalid, while IV countersued in Delaware, accusing Xilinx of infringement. The trial in the Xilinx case is scheduled to begin in Delaware next month.

  • WASHINGTON, April 18- U.S. Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd to stay a lower-court ruling in a patent case that favored the developers of generic versions of Teva's top-selling multiple sclerosis drug.

  • SAN FRANCISCO, April 17- A U.S. judge on Thursday rejected a request by patent consortium Rockstar to transfer patent litigation from Google Inc's home turf in California to Texas, according to a court ruling.

  • SAN FRANCISCO, April 17- A federal judge in California on Thursday rejected a request by patent consortium Rockstar to transfer patent litigation against Google Inc to Texas, according to a court ruling.

  • WASHINGTON, April 14- Generic drug manufacturers on Monday asked the U.S. Supreme Court to allow a lower court ruling favoring them to take effect while the high court considers an appeal in a patent fight over Teva Pharmaceutical Industries Ltd's top-selling multiple sclerosis drug, Copaxone.

  • Why Apple's the underdog in this Samsung trial Thursday, 10 Apr 2014 | 3:23 PM ET

    Apple is making some broad claims about what it owns and will have to make a strong case to prove it actually deserves as much as it is asking for.

  • MUMBAI, April 10- India's Natco Pharma Ltd has formally asked the Indian patent office to deny U.S. drugmaker Gilead Sciences Inc's new hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said.

  • CNBC's Jim Cramer speaks with Robert Hugin, Celgene chairman & CEO, about America's need to build a stronger and more sustainable ecosystem of innovation to continue as the world leader in biomedical innovation.

  • Alkermes is a true drug innovator: CEO     Thursday, 10 Apr 2014 | 8:21 AM ET

    Richard Pops, chairman & CEO of Alkermes, discusses Alkermes' new injectable drug for the treatment of schizophrenia. We have more psychiatry products in our pipeline, reveals Pops.

  • Eli Lilly CEO: We keep investing in R&D     Thursday, 10 Apr 2014 | 6:51 AM ET

    John Lechleiter, Chairman, President & CEO of Eli Lilly, discusses the company's growth plans as products come off patent and consumers move to generic drugs.

  • Technology group Kudelski says Apple infringed patents Thursday, 10 Apr 2014 | 1:53 AM ET

    ZURICH, April 10- Technology group Kudelski said its OpenTV and Nagravision subsidiaries have filed a lawsuit against Apple Inc in a court in northern California alleging the iPhone maker has infringed five U.S. patents. Kudelski did not give further details about the patent suit. Apple was not immediately available for comment.

  • NXP in April 2012 sued BlackBerry, then known as Research in Motion, alleging that versions of the BlackBerry phone and PlayBook tablet infringed patents related to the design, data transmission and other features of those devices.

  • Apple, Intertrust settle year-old patent suit Friday, 4 Apr 2014 | 2:27 PM ET

    April 4- Apple Inc has agreed to settle a year-old patent infringement lawsuit with Intertrust Technologies Corp, a software firm owned by a group that includes Sony Corp and Philips, according to court filings. Intertrust filed a lawsuit against Apple in March 2013 saying the iPhone maker infringed 15 patents relating to security.

  • ZURICH, April 3- Novartis has taken India's Biocon to court for infringing the patent on its diabetes drug Galvus, the Swiss drugmaker said in a statement on Thursday. In a hearing that took place on March 28, the Delhi court ordered that Biocon cannot manufacture, sell or export vildagliptin until the next court hearing, Novartis said in an emailed statement.

  • Samsung: Apple's claims are 'gross exaggeration' Tuesday, 1 Apr 2014 | 4:47 PM ET
    A man holds a Samsung Electronics Co. Galaxy S4 smartphone, left, next to an Apple Inc. iPhone 5.

    Samsung began its opening argument on Tuesday, saying that Apple's patents aren't nearly as broad or important as the company claims.

  • UPDATE 2-Marvell patent verdict grows to $1.54 billion Tuesday, 1 Apr 2014 | 11:15 AM ET

    April 1- A federal judge ordered Marvell Technology Group Ltd to pay nearly $1.54 billion to Carnegie Mellon University for selling billions of semiconductors that infringed the school's two hard disk drive patents.

  • O'Leary: Business is war; Apple strategy great     Tuesday, 1 Apr 2014 | 11:00 AM ET

    CNBC's Jon Fortt and investor Kevin O'Leary of "Shark Tank," discusses Apple's patent infringement battle with Samsung.

  • Apple and Samsung are back in court today for the latest chapter in their ongoing patent battle, reports CNBC's Josh Lipton.

  • SAN JOSE, Calif., April 1- Apple and Samsung return to federal court on Tuesday for opening statements in their latest patent battle, with the iPhone maker expected to present more detailed evidence in its attempt to win a U.S. ban on sales of several Samsung smartphones.